ORMP

ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. · NASDAQ
Market Closed
3.57
▼ ⁦-3.25%⁩ (-0.12)
Post-market3.570.00% (0.00)
Market Cap$155.2M
Beta1.28
52w Low52w High
2.385.47
Last Week
⁦-3.77%⁩
Last Month
⁦-13.35%⁩
Last 3 Months
⁦-25.93%⁩
Last Year
⁦+42.80%⁩
Open on chart
Premium content
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$700 / yr
Monthly plan
$99 / mo

No current analyst coverage is available for this listing yet.

Which listings have analyst coverage?

EL7 refreshes analyst ratings and price targets for active company listings on Nasdaq, the New York Stock Exchange and NYSE American, including US-listed depositary receipts. Funds (including ETFs and mutual funds), OTC listings and listings on other exchanges are outside this coverage. Some eligible listings may have no published target or analyst call in the past 12 months.

EL7 checks for new ratings several times on weekdays, refreshes consensus targets on weekdays and updates monthly rating history once a month.

Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
  • P/E (TTM)
    1.04x
    5.82x46.58x
    Very cheap
  • Forward P/E
    —
    —
  • EV / EBITDA
    2.93x
    3.71x29.64x
    Very cheap
  • FCF Yield
    -2.1%
    -99.3%7.8%
    Strong
  • Revenue Growth YoY
    -100.0%
    -48.8%73.2%
    Weak
  • EPS Growth YoY
    246.5%
    -103.1%98.8%
    Exceptional
  • Gross Margin
    —
    —
  • ROIC
    -22.2%
    -150.5%16.1%
    Strong
  • Net Debt / EBITDA
    -0.65x
    0.00x1.99x
    Net cash
  • Dividend Yield
    6.8%
    0.3%4.6%
    High
  • Payout Ratio
    7.2%
    9.9%92.8%
    Low
  • Altman Z-Score
    1.55
    -17.7515.77
    Above average
Financial Analysis
Related News

Frequently Asked Questions

What is Oramed Pharmaceuticals Inc. stock?▼

Oramed Pharmaceuticals Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Oramed Pharmaceuticals Inc.?▼

You can buy Oramed Pharmaceuticals Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Oramed Pharmaceuticals Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Oramed Pharmaceuticals Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Oramed Pharmaceuticals Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.